-
Piloting Structured Expert Elicitation: An Exploratory Case Study of Practical Implementation
Sep 9, 2025, 16:22 PM -
Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030
Sep 9, 2025, 16:22 PM -
Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries’ Data Quality
Sep 9, 2025, 16:22 PM -
Integrated Sustainability Assessment of the Population-Based Colorectal Cancer Screening Program in Flanders
Sep 9, 2025, 16:22 PM -
US Payer Assessment of the Utility and Impact of Value Dossiers on Decision Making
Sep 9, 2025, 16:22 PM -
Potential Impacts of Improvement in Turnaround Time
Sep 9, 2025, 16:22 PM -
Potential Nephrocalcinosis Risk Linked to Nusinersin: Insights from FAERS-Based Signal Detection and Molecular Docking
Sep 9, 2025, 16:22 PM -
Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective
Sep 9, 2025, 16:22 PM -
Economic Burden of Progressive Pulmonary Fibrosis (PPF) in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
The Impact of Burosumab on the Clinical and Economic Burden of X-Linked Hypophosphatemia in Adult Patients in France
Sep 9, 2025, 16:22 PM -
The French Transitional Coverage Pathway (PECT) for Innovative Therapeutic Medical Devices: A Four-Year Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK
Sep 9, 2025, 16:22 PM -
Therapeutic Drug Monitoring and Selective Use of Glucarpidase in High-Dose Methotrexate Therapy: A Cost Analysis From the Algerian Payer Perspective
Sep 9, 2025, 16:22 PM -
Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among At-Risk and High-Risk Adults in India
Sep 9, 2025, 16:22 PM -
Modeling Intelligence Quotient (IQ) Changes Relative to Blood Phe Levels in Individuals With Phenylketonuria (PKU) Treated With Sepiapterin and Sapropterin Dihydrochloride
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM
